The "Tilted Peptide Theory" links membrane insertion properties and fusogenicity of viral fusion peptides

Protein and Peptide Letters

Volumn 16, Issue 7, 2009, Pages 718-725

  Charloteaux, B ^a   Lorin, A ^b   Brasseur, R ^a   Lins, L ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Molecular modelling; Tilted peptide; Viral fusion

Indexed keywords

PEPTIDE; VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; MOLECULAR GENETICS; MUTATION; VIRUS ENTRY;

AMINO ACID SEQUENCE; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION;

EID: 67849104242     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609788681724     Document Type: Article

References (85)

1. Earp, L. J.; Delos, S. E.; Park, H. E.; White, J. M. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol., 2005, 285(1), 25-66.
2. Skehel, J. J.; Wiley, D. C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. An. Rev. Biochem., 2000, 69(3), 531-569.
3. Harrison, S. C. Mechanism of membrane fusion by viral envelope proteins. Virus Struct. Assembly, 2005, 64(2), 231-261.
4. Colman, P. M.; Lawrence, M. C. The structural biology of type I viral membrane fusion. Nature Rev. Mol. Cell Biol., 2003, 4(4), 309-319.
5. Carr, C. M.; Kim, P. S. A Spring-Loaded Mechanism for the Conformational Change of Influenza Hemagglutinin. Cell, 1993, 73(4), 823-832.
6. Carr, C. M.; Chaudhry, C.; Kim, P. S. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc. Natl. Acad. Sci. USA, 1997, 94(26), 14306-14313.
7. White, J. M. Membrane-Fusion. Science, 1992, 258(5084), 917-924.
8. Gallaher, W. R. Detection of A Fusion Peptide Sequence in the Transmembrane Protein of Human-Immunodeficiency-Virus. Cell, 1987, 50(3), 327-328.
9. Durell, S. R.; Martin, I.; Ruysschaert, J. M.; Shai, Y.; Blumenthal, R. What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion. Mol. Membr. Biol., 1997, 14(3), 97-112.
10. Bosch, M. L.; Earl, P. L.; Fargnoli, K.; Picciafuoco, S.; Giombini, F.; Wongstaal, F.; Franchini, G. Identification of the Fusion Peptide of Primate Immunodeficiency Viruses. Science, 1989, 244(4905), 694-697.
11. Freed, E. O.; Myers, D. J.; Risser, R. Characterization of the Fusion Domain of the Human-Immunodeficiency-Virus Type-1 Envelope Glycoprotein Gp41. Proc. Natl. Acad. Sci. USA, 1990, 87(12), 4650-4654.
12. Durrer, P.; Galli, C.; Hoenke, S.; Corti, C.; Gluck, R.; Vorherr, T.; Brunner, J. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J. Biol. Chem., 1996, 271(23), 13417-13421.
13. Peisajovich, S. G.; Shai, Y. Viral fusion proteins: multiple regions contribute to membrane fusion. Biochim. Biophys. Acta-Biomembranes, 2003, 1614(1), 122-129.
14. Weissenhorn, W.; Dessen, A.; Harrison, S. C.; Skehel, J. J.; Wiley, D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature, 1997, 387(6631), 426-430.
15. Nieva, J. L.; Agirre, A. Are fusion peptides a good model to study viral cell fusion? Biochim. Biophys. Acta-Biomembranes, 2003, 1614(1), 104-115.
16. Martin, I.; Ruysschaert, J. M.; Epand, R. M. Role of the N-terminal peptides of viral envelope proteins in membrane fusion. Adv. Drug Deliv. Rev., 1999, 38(3), 233-255.
17. Epand, R. M. Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta, 2003, 1614(1), 116-121.
18. Brasseur, R.; Lorge, P.; Goormaghtigh, E.; Ruysschaert, J. M.; Espion, D.; Burny, A. The mode of insertion of the paramyxovirus F1 N-terminus into lipid matrix, an initial step in host cell/virus fusion. Virus Genes, 1988, 1(4), 325-332.
19. Brasseur, R.; Vandenbranden, M.; Cornet, B.; Burny, A.; Ruysschaert, J. M. Orientation Into the Lipid Bilayer of An Asymmetric Amphipathic Helical Peptide Located at the N-Terminus of Viral Fusion Proteins. Biochim. Biophys. Acta, 1990, 1029(2), 267-273.
20. Efremov, R. G.; Nolde, D. E.; Volynsky, P. E.; Chernyavsky, A. A.; Dubovskii, P. V.; Arseniev, A. S. Factors important for fusogenic activity of peptides: molecular modeling study of analogs of fusion peptide of influenza virus hemagglutinin. FEBS Lett., 1999, 462(1-2), 205-210.
21. Lins, L.; Charloteaux, B.; Thomas, A.; Brasseur, R. Computational study of lipid-destabilizing protein fragments: Towards a comprehensive view of tilted peptides. Prot. Struct. Funct. Genet., 2001, 44(4), 435-447.
22. Voneche, V.; Portelle, D.; Kettmann, R.; Willems, L.; Limbach, K.; Paoletti, E.; Ruysschaert, J. M.; Burny, A.; Brasseur, R. Fusogenic Segments of Bovine Leukemia-Virus and Simian Immunodeficiency Virus Are Interchangeable and Mediate Fusion by Means of Oblique Insertion in the Lipid Bilayer of Their Target-Cells. Proc. Natl. Acad. Sci. USA, 1992, 89(9), 3810-3814.
23. Adam, B.; Lins, L.; Stroobant, V.; Thomas, A.; Brasseur, R. Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide. J. Virol, 2004, 78(4), 2131-2136.
24. Martin, I.; Schaal, H.; Scheid, A.; Ruysschaert, J. M. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J. Virol., 1996, 70(1), 298-304.
25. Martin, I.; Dubois, M. C.; Defrisequertain, F.; Saermark, T.; Burny, A.; Brasseur, R.; Ruysschaert, J. M. Correlation Between Fusogenicity of Synthetic Modified Peptides Corresponding to the Nh2-Terminal Extremity of Simian Immunodeficiency Virus Gp32 and Their Mode of Insertion Into the Lipid Bilayer-An Infrared-Spectroscopy Study. J. Virol., 1994, 68(2), 1139-1148.
26. Luneberg, J.; Martin, I.; Nussler, F.; Ruysschaert, J. M.; Herrmann, A. Structure and Topology of the Influenza-Virus Fusion Peptide in Lipid Bilayers. J. Biol. Chem., 1995, 270(46), 27606-27614.
27. Bradshaw, J. P.; Darkes, M. J. M.; Harroun, T. A.; Katsaras, J.; Epand, R. M. Oblique membrane insertion of viral fusion peptide probed by neutron diffractions. Biochemistry, 2000, 39(22), 6581-6585.
28. Han, X.; Bushweller, J. H.; Cafiso, D. S.; Tamm, L. K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol., 2001, 8(8), 715-720.
29. Lai, A. L.; Park, H.; White, J. M.; Tamm, L. K. Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity. J. Biol. Chem., 2006, 281(9), 5760-5770.
30. Brasseur, R.; Pillot, T.; Lins, L.; Vandekerckhove, J.; Rosseneu, M. Peptides in membranes: Tipping the balance of membrane stability. Tibs, 1997, 22(5), 167-171.
31. Lins, L.; Flore, C.; Chapelle, L.; Talmud, P. J.; Thomas, A.; Brasseur, R. Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III. Prot. Eng., 2002, 15(6), 513-520.
32. Ravault, S.; Soubias, O.; Saurel, O.; Thomas, A.; Brasseur, R.; Milon, A. Fusogenic Alzheimer's peptide fragment A beta (29-42) in interaction with lipid bilayers: Secondary structure, dynamics, and specific interaction with phosphatidyl ethanolamine polar heads as revealed by solid-state NMR. Prot. Sci., 2005, 14(5), 1181-1189.
33. Pillot, T.; Goethals, M.; Vanloo, B.; Talussot, C.; Brasseur, R.; Vandekerckhove, J.; Rosseneu, M.; Lins, L. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. J. Biol. Chem., 1996, 271(46), 28757-28765.
34. Pillot, T.; Lins, L.; Goethals, M.; Vanloo, B.; Baert, J.; Vandekerckhove, J.; Rosseneu, M.; Brasseur, R. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. J. Mol. Biol., 1997, 274(3), 381-393.
35. Crowet, J. M.; Lins, L.; Dupiereux, I.; Elmoualija, B.; Lorin, A.; Charloteaux, B.; Stroobant, V.; Heinen, E.; Brasseur, R. Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity. Prot. Struct. Funt. Genet., 2007, 68(4), 936-947.
36. Lins, L.; Brasseur, R. Tilted peptides: a structural motif involved in protein membrane insertion? J. Pept. Sci., 2008, 14(4), 416-422.
37. Peuvot, J.; Schanck, A.; Lins, L.; Brasseur, R. Are the fusion processes involved in birth, life and death of the cell depending on tilted insertion of peptides into membranes? J. Theor. Biol., 1999, 198(2), 173-181.
38. Lins, L.; Charloteaux, B.; Heinen, C.; Thomas, A.; Brasseur, R. "De novo" design of peptides with specific lipid-binding properties. Biophys. J., 2006, 90(2), 470-479.
39. Brasseur, R. Tilted peptides: a motif for membrane destabilization (hypothesis). Mol. Membrane Biol., 2000, 17(1), 31-40.
40. Brasseur, R. Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculations. J. Biol. Chem., 1991, 266(24), 16120-16127.
41. Harris, F.; Wallace, J.; Phoenix, D. A. Use of hydrophobic moment plot methodology to aid the identification of oblique orientated alpha-helices. Mol. Membrane Biol., 2000, 17(4), 201-207.
42. Lorin, A.; Thomas, A.; Stroobant, V.; Brasseur, R.; Lins, L. Lipiddestabilising properties of a peptide with structural plasticity. Chem. Phys. Lipids, 2006, 141(1-2), 185-196.
43. Decout, A.; Labeur, C.; Vanloo, B.; Goethals, M.; Vandekerckhove, J.; Brasseur, R.; Rosseneu, M. Contribution of the hydrophobicity gradient to the secondary structure and activity of fusogenic peptides. Mol. Membrane Biol., 1999, 16(3), 237-246.
44. Pillot, T.; Lins, L.; Goethals, M.; Vanloo, B.; Baert, J.; Vandekerckhove, J.; Rosseneu, M.; Brasseur, R. The 118-135 peptide lot the human prion protein forms amyloid fibrils and induces liposome fusion. J. Mol. Biol., 1997, 274(3), 381-393.
45. Lambert, G.; Decout, A.; Vanloo, B.; Rouy, D.; Duverger, N.; Kalopissis, A.; Vadekerckhove, J.; Chambaz, J.; Brasseur, R.; Rosseneu, M. The C-terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins. Eur. J. Biochem., 1998, 253(1), 328-338.
46. Horth, M.; Lambrecht, B.; Khim, M. C. L.; Bex, F.; Thiriart, C.; Ruysschaert, J. M.; Burny, A.; Brasseur, R. Theoretical and Functional-Analysis of the Siv Fusion Peptide. EMBO J., 1991, 10(10), 2747-2755.
47. Kamath, S.; Wong, T. C. Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulation. Biophys. J., 2002, 83(1), 135-143.
48. Epand, R. M. Membrane fusion. Biosci. Rep., 2000, 20(6), 435-441.
49. Siegel, D. P. The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion. Biophys. J., 1999, 76(1), 291-313.
50. Siegel, D. P. Stalk Structures As Intermediates in Membrane-Fusion and Bilayer Nonbilayer Phase-Transitions. Biophys. J., 1993, 64(2), A186-A186.
51. El Kirat, K.; Dufrene, Y. F.; Lins, L.; Brasseur, R. The SIV tilted peptide induces cylindrical reverse micelles in supported lipid bilayers. Biochem, 2006, 45(30), 9336-9341.
52. Lins, L.; Decaffmeyer, M.; Thomas, A.; Brasseur, R. Relationships between the orientation and the structural properties of peptides and their membrane interactions. Biochim. Biophys. Acta, 2008, 1778(7-8), 1537-1544.
53. Martin, I.; Defrisequertain, F.; Decroly, E.; Vandenbranden, M.; Brasseur, R.; Ruysschaert, J. M. Orientation and Structure of the Nh2-Terminal Hiv-1 Gp41 Peptide in Fused and Aggregated Liposomes. Biochim. Biophys. Acta, 1993, 1145(1), 124-133.
54. Delahunty, M. D.; Rhee, I.; Freed, E. O.; Bonifacino, J. S. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: Identification of critical glycine residues. virology, 1996, 218(1), 94-102.
55. Gordon, L. M.; Mobley, P. W.; Pilpa, R.; Sherman, M. A.; Waring, A. J. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using C-13-enhanced Fourier transform infrared spectroscopy. Biochim. Biophys. Acta-Biomembranes, 2002, 1559(2), 96-120.
56. Pritsker, M.; Rucker, J.; Hoffman, T. L.; Doms, R. W.; Shai, Y. Effect of nonpolar substitutions of the conserved Phe(11) in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes. Biochemistry, 1999, 38(35), 11359-11371.
57. Ducarme, P.; Rahman, M.; Brasseur, R. IMPALA: A simple restraint field to simulate the biological membrane in molecular structure studies. Prot. Struct. Funct. Genet., 1998, 30(4), 357-371. (Pubitemid 28117656)
58. Charloteaux, B.; Lorin, A.; Crowet, J. M.; Stroobant, V.; Lins, L.; Thomas, A.; Brasseur, R. The N-terminal 12 residue long peptide of HIV gp41 is the minimal peptide sufficient to induce significant T-cell-like membrane destabilization in vitro. J. Mol. Biol., 2006, 359(3), 597-609.
59. Lorin, A.; Lins, L.; Stroobant, V.; Brasseur, R.; Charloteaux, B. The minimal fusion peptide of simian immunodeficiency virus corresponds to the 11 first residues of gp32. J. Pept. Sci., 2008, 14(4), 423-428.
60. Lorin, A.; Lins, L.; Stroobant, V.; Brasseur, R.; Charloteaux, B. Determination of the minimal fusion peptide of bovine leukemia virus gp30. Biochem. Biophys. Res. Commun., 2007, 355(3), 649-653.
61. Buchschacher, G. L., Jr.; Freed, E. O.; Panganiban, A. T. Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant. J. Virol., 1995, 69(2), 1344-1348.
62. Thomas, A.; Deshayes, S.; Decaffmeyer, M.; Van Eyck, M. H.; Charloteaux, B.; Brasseur, R. Prediction of peptide structure: how far are we? Prot. Struct. Funct. Genet., 2006, 65(4), 889-897.
63. Deshayes, S.; Decaffmeyer, M.; Brasseur, R.; Thomas, A. Structural polymorphism of two CPP: An important parameter of activity. Biochim. Biophys. Acta-Biomembranes, 2008, 1778(5), 1197-1205
64. Gordon, L. M.; Curtain, C. C.; Zhong, Y. C.; Kirkpatrick, A.; Mobley, P. W.; Waring, A. J. The Amino-Terminal Peptide of Hiv-1 Glycoprotein-41 Interacts with Human Erythrocyte-Membranes-Peptide Conformation, Orientation and Aggregation. Biochim. Biophys. Acta, 1992, 1139(4), 257-274.
65. Jaroniec, C. P.; Kaufman, J. D.; Stahl, S. J.; Viard, M.; Blumenthal, R.; Wingfield, P. T.; Bax, A. Structure and dynamics of micelleassociated human immunodeficiency virus gp41 fusion domain. Biochemisty, 2005, 44(49), 16167-16180.
66. Pereira, F. B.; Goni, F. M.; Muga, A.; Nieva, J. L. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: Dose and sequence effects. Biophys. J., 1997, 73(4), 1977-1986.
67. Rafalski, M.; Lear, J. D.; Degrado, W. F. Phospholipid Interactions of Synthetic Peptides Representing the N-Terminus of Hiv Gp41. Biochemistry, 1990, 29(34), 7917-7922.
68. Sackett, K.; Shai, Y. The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: A C-13 FTIR study. J. Mol. Biol., 2005, 350(4), 790-805.
69. Yang, J.; Gabrys, C. M.; Weliky, D. P. Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide. Biochemistry, 2001, 40(27), 8126-8137.
70. Yang, R.; Yang, J.; Weliky, D. P. Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides. Biochemistry, 2003, 42(12), 3527-3535.
71. Yang, R.; Prorok, M.; Castellino, F. J.; Weliky, D. P. A trimeric HIV-1 fusion peptide construct which does not self-associate in aqueous solution and which has 15-fold higher membrane fusion rate. J. Am. Chem. Soc., 2004, 126(45), 14722-14723.
72. Peisajovich, S. G.; Epand, R. F.; Pritsker, M.; Shai, Y.; Epand, R. M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry, 2000, 39(7), 1826-1833.
73. Wexler-Cohen, Y.; Sackett, K.; Shai, Y. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils. Biochemistry, 2005, 44(15), 5853-5861.
74. Korazim, O.; Sackett, K.; Shai, Y. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended. J. Mol. Biol., 2006, 364(5), 1103-1117.
75. Castano, S.; Desbat, B. Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi-and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy. Biochim. Biophys. Acta-Biomembranes, 2005, 1715(2), 81-95.
76. Gordon, L. M.; Mobley, P. W.; Lee, W.; Eskandari, S.; Kaznessis, Y. N.; Sherman, M. A.; Waring, A. J. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using C-13-enhanced Fourier transform infrared spectroscopy. Prot. Sci., 2004, 13(4), 1012-1030.
77. Saez-Cirion, A.; Nieva, J. L. Conformational transitions of membrane-bound HIV-1 fusion peptide. Biochim. Biophys. Acta-Biomembranes, 2002, 1564(1), 57-65.
78. Buzon, V.; Padros, E.; Cladera, J. Interaction of fusion peptides from HIV gp41 with membranes: A time-resolved membrane binding, lipid mixing, and structural study. Biochemistry, 2005, 44(40), 13354-13364.
79. Li, Y.; Tamm, L. K. Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers. Biophys. J., 2007, 93(3), 876-885.
80. Tamm, L. K.; Lai, A. L.; Li, Y. Combined NMR and EPR spectroscopy to determine structures of viral fusion domains in membranes. Biochim. Biophys. Acta, 2007, 1768(12), 3052-3060.
81. Weise, K.; Reed, J. Fusion Peptides and Transmembrane Domains of Fusion Proteins are Characterized by Different but Specific Structural Properties. Chembiochem., 2008, 9(6), 934-943
82. Cohen, F. S.; Melikyan, G. B. The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J. Membrane Biol., 2004, 199(1), 1-14.
83. Chang, D. K.; Cheng, S. F.; Kantchev, E. A.; Lin, C. H.; Liu, Y. T. Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. BMC Biol., 2008, 6, 2.
84. Wilson, I. A.; Skehel, J. J.; Wiley, D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature, 1981, 289(5796), 366-373.
85. Schroth-Diez, B.; Ludwig, K.; Baljinnyam, B.; Kozerski, C.; Huang, Q.; Herrmann, A. The role of the transmembrane and of the intraviral domain of glycoproteins in membrane fusion of enveloped viruses. Biosci. Rep., 2000, 20(6), 571-595.